[Code of Federal Regulations]
[Title 10, Volume 1]
[Revised as of January 1, 2004]
From the U.S. Government Printing Office via GPO Access
[CITE: 10CFR35.14]

[Page 572]
 
                            TITLE 10--ENERGY
 
                CHAPTER I--NUCLEAR REGULATORY COMMISSION
 
PART 35--MEDICAL USE OF BYPRODUCT MATERIAL--Table of Contents
 
                     Subpart A--General Information
 
Sec. 35.14  Notifications.

    (a) A licensee shall provide the Commission a copy of the board 
certification, the Commission or Agreement State license, the permit 
issued by a Commission master material licensee, the permit issued by a 
Commission or Agreement State licensee of broad scope, or the permit 
issued by a Commission master material license broad scope permittee for 
each individual no later than 30 days after the date that the licensee 
permits the individual to work as an authorized user, an authorized 
nuclear pharmacist, or an authorized medical physicist, under Sec. 
35.13 (b)(1) through (b)(4).
    (b) A licensee shall notify the Commission no later than 30 days 
after:
    (1) An authorized user, an authorized nuclear pharmacist, a 
Radiation Safety Officer, or an authorized medical physicist permanently 
discontinues performance of duties under the license or has a name 
change;
    (2) The licensee's mailing address changes;
    (3) The licensee's name changes, but the name change does not 
constitute a transfer of control of the license as described in Sec. 
30.34(b) of this chapter; or
    (4) The licensee has added to or changed the areas of use identified 
in the application or on the license where byproduct material is used in 
accordance with either Sec. 35.100 or Sec. 35.200.
    (c) The licensee shall send the documents required in this section 
to the appropriate address identified in Sec. 30.6 of this chapter.

[67 FR 20370, Apr. 24, 2002, as amended at 68 FR 58805, Oct. 10, 2003]